ReviewPublished 12 October 2026Tumor antigens across cancer progression: from immune recognition and selection to precision cancer immunotherapyStanley P. LeongFrontiers in Immunologydoi 10.3389/fimmu.2026.1939919
ReviewPublished 12 October 2026Histotripsy in tumor therapy: advances in non-thermal mechanical ablation, immune modulation, and clinical translationYangyang Ma · Xinan Long · Jiangpeng Cheng · Lizhi NiuFrontiers in Immunologydoi 10.3389/fimmu.2026.1858144
ReviewPublished 9 October 2026Progress on therapeutic mRNA vaccines for cancerSiyu Wu · Huarong Liao · Wei ZhangFrontiers in Oncologydoi 10.3389/fonc.2026.1980190
Original ResearchPublished 16 September 2026Adoptive T Cell therapy for cancer and autoimmune disease: current advances, challenges, and future directionsQiu-Hong Bao · Angel Wu · Jianming Pang · Junwei Wang · Qingqing Chen · SuWen WuOncology Reviewsdoi 10.3389/or.2026.1905358
ReviewPublished 23 February 2026The role of necroptosis as a possible therapeutic target in multiple myeloma: the emerging roles of necroptosisDuygu AydemirFrontiers in Hematologydoi 10.3389/frhem.2026.1686097
